TerminatedPhase 2NCT01002534

Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Principal Investigator
Patrick LEBECQUE, MD, PhD
Cliniques universitaires St.Luc (Université catholique de Louvain)
Intervention
Vardenafil(drug)
Enrollment
5 enrolled
Eligibility
14 years · All sexes
Timeline
20112018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01002534 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials